Therapeutic Options for Visceral Leishmaniasis

被引：0
作者：
Begoña Monge-Maillo
Rogelio López-Vélez
机构：
[1] Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS),Tropical Medicine and Clinical Parasitology, Infectious Diseases Department, Ramón y Cajal Hospital
来源：
Drugs | 2013年 / 73卷
关键词：
Allopurinol; Visceral Leishmaniasis; Leishmaniasis; Pentamidine; Liposomal Amphotericin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geographical area of the infection, development of resistance to habitual treatments, HIV co-infection, malnourishment and other concomitant infections. This article provides an exhaustive review of the literature regarding studies published on the treatment of VL, and gives therapeutic recommendations stratified according to their level of evidence, the species of Leishmania implicated and the geographical location of the infection.
引用
收藏
页码：1863 / 1888
页数：25
相关论文
共 500 条
  • [1] van Griensven J(2012)Visceral leishmaniasis Infect Dis Clin North Am 26 309-322
  • [2] Diro E(2012)Leishmaniasis worldwide and global estimates of its incidence PLoS One 7 e35671-63
  • [3] Alvar J(2013)Leishmaniasis: an update of current pharmacotherapy Expert Opin Pharmacother 14 53-274
  • [4] Velez ID(2006)Chemotherapy in the treatment and control of leishmaniasis Adv Parasitol 61 223-126
  • [5] Bern C(2006)Drug resistance in leishmaniasis Clin Microbiol Rev 19 111-359
  • [6] Sundar S(2008)The relationship between leishmaniasis and AIDS: the second 10 years Clin Microbiol Rev 21 334-1156
  • [7] Chakravarty J(2010)Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines Clin Infect Dis 51 1147-854
  • [8] Alvar J(2001)Infectious Diseases Society of America. Guide to development of practice guidelines Clin Infect Dis 32 851-1043
  • [9] Croft S(1996)Fluconazole plus allopurinol in treatment of visceral leishmaniasis J Antimicrob Chemother 37 1042-559
  • [10] Olliaro P(1981)Allopurinol in the treatment of visceral leishmaniasis Trans R Soc Trop Med Hyg 75 556-612
12345678910